The relationship between cannabis and male infertility, sexual health, and neoplasm: a systematic review

Andrology

Volumn 7, Issue 2, 2019, Pages 139-147

  Rajanahally, S ^a   Raheem, O ^b   Rogers, M ^c   Brisbane, W ^a   Ostrowski, K ^a   Lendvay, T ^d   Walsh, T ^a  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^d SEATTLE CHILDREN S HOSPITAL   (United States)

Author keywords

cannabis; infertility; marijuana; neoplasm; sexual health

Indexed keywords

CANNABINOID; CANNABIS;

EMBASE; HUMAN; MALE; MALE INFERTILITY; MEDLINE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SEXUAL HEALTH; SEXUAL INTERCOURSE; SYSTEMATIC REVIEW; URINARY TRACT TUMOR; DRUG EFFECT; MALE GENITAL SYSTEM; PATHOLOGY;

CANNABIS; GENITALIA, MALE; HUMANS; INFERTILITY, MALE; MALE; UROLOGIC NEOPLASMS;

EID: 85061570663     PISSN: 20472919     EISSN: 20472927     Source Type: Journal    
DOI: 10.1111/andr.12585     Document Type: Review

References (60)

1. Abel EL. (1981) Marihuana and sex: A critical survey. Drug Alcohol Depend 8, 1–22.
2. Abernathy D. (2017) The State of Legal Marijuana Markets: 5th Edition. ArcView Group.
3. Amoako A, Marczylo T, Marczylo E, Elson J, Willets J, Taylor A & Konje J. (2013a) Anandamide modulates human sperm motility: Implications for men with asthenozoospermia and oligoasthenoteratozoospermia. Hum Reprod 28, 2058–2066.
4. Amoako A, Gebeh A, Marczylo E, Willets J, Elson J, Marczylo T & Konje J. (2013b) Impact of reference gene selection for type 2 cannabinoid receptor gene expression studies in human spermatozoa. Andrologia 45(4), 278–284.
5. Argiolas A & Melis M. (2004) The role of oxytocin and the paraventricular nucleus in the sexual behaviour of male mammals. Physiol Behav 83, 309–317.
6. Aversa A, Rossi F, Francomano D, Bruzziches R, Bertone C, Santiemma V & Spera G. (2008) Early endothelial dysfunction as a marker of vasculogenic erectile dysfunction in young habitual cannabis users. Int J Impot Res 20, 566–573.
7. Block R, Farinpour R & Schlechte J. (1991) Effects of chronic marijuana use on testosterone, luteinizing hormone, follicle stimulating hormone, prolactin and cortisol in men and women. Drug Alcohol Depend 28, 121–128.
8. Caplan G & Brigham B. (1990) Marijuana smoking and carcinoma of the tongue. Is there an association? Cancer 66, 1005–1006.
9. Center for Behavioral Health Statistics and Quality. (2017) 2016 National Survey on Drug Use and Health: Detailed Tables. Substance Abuse and Mental Health Services Administration, Rockville, MD.
10. Chacko J, Heiner J, Siu W, Macy M & Terris M. (2006) Association between marijuana use and transitional cell carcinoma. Urology 67, 100–104.
11. Chopra G & Jandu B. (1976) Psychoclinical effects of long-term marijuana use in 275 Indian chronic users. A comparative assessment of effects in Indian and USA users. Ann N Y Acad Sci 282, 95–108.
12. Close C, Roberts P & Berger R. (1990) Cigarettes, alcohol and marijuana are related to pyospermia in infertile men. J Urol 144, 900–903.
13. Cohen S. (1976) The 94-day cannabis study. Ann N Y Acad Sci 282, 211–220.
14. Cohen S. (1982) Cannabis and sex: Multifaceted paradoxes. J Psychoactive Drugs 14, 55–58.
15. Cone E, Johnson R, Moore J & Roache J. (1986) Acute effects of smoking marijuana on hormones, subjective effects and performance in male human subjects. Pharmacol Biochem Behav 24, 1749–1754.
16. Cushman P Jr. (1975) Plasma testosterone levels in healthy male marijuana smokers. Am J Drug Alcohol Abuse 2, 269–275.
17. Daling J, Doody D, Sun X, Trabert B, Weiss N, Chen C, Biggs M, Starr J, Dey S & Schwartz S. (2009) Association of marijuana use and the incidence of testicular germ cell tumors. Cancer 115, 1215–1223.
18. Dax E, Pilotte N, Adler W, Nagel J & Lange W. (1989) The effects of 9-ene-tetrahydrocannabinol on hormone release and immune function. J Steroid Biochem 34(1–6), 263–270.
19. Dieckmann K & Pichlmeier U. (2004) Clinical epidemiology of testicular germ cell tumors. World J Urol 22, 2–14.
20. Fossa S, Chen J, Schonfeld S, McGlynn K, McMaster M, Gail M & Travis L. (2005) Risk of contralateral testicular cancer: A population-based study of 29,515 U.S. men. J Natl Cancer Inst 97, 1056–1066.
21. Friedrich G, Nepita W & Andre T. (1990) Serum testosterone concentrations in cannabis and opiate users. Beitr Gerichtl Med 48, 57–66.
22. Gundersen T, Jorgensen N, Andersson A, Bang A, Nordkap L, Skakkebaek N, Priskorn L, Juul A & Jensen T. (2015) Association between use of marijuana and male reproductive hormones and semen quality: A study among 1,215 healthy young men. Am J Epidemiol 182, 473–481.
23. Gurney J, Shaw C, Stanley J, Signal V & Sarfati D. (2015) Cannabis exposure and risk of testicular cancer: A systematic review and meta-analysis. BMC Cancer 15, 897.
24. Halikas J, Weller R & Morse C. (1982) Effects of regular marijuana use on sexual performance. J Psychoactive Drugs 14, 59–70.
25. Hembree W, Nahas G, Zeidenberg P & Huang H. (1978) Changes in human spematozoa associated with high dose marihuana smoking. Adv Biosci 22–23, 429–439.
26. Howlett A. (2005) Cannabinoid receptor signaling. Handb Exp Pharmacol, 53–79.
27. Huestis M & Cone E. (1998) Urinary excretion half-life of 11-nor-9-carboxy-delta9-tetrahydrocannabinol in humans. Ther Drug Monit 20, 570–576.
28. Johnson S, Phelps D & Cottler L. (2004) The association of sexual dysfunction and substance use among a community epidemiological sample. Arch Sex Behav 33, 55–63.
29. Kado N, Manson C, Eisenstadt E & Hsieh D. (1985) The kinetics of mutagen excretion in the urine of cigarette smokers. Mutat Res 157, 227–233.
30. Koff W. (1974) Marijuana and sexual activity. J Sex Res 10, 194–204.
31. Kolodny R, Masters W, Kolodner R & Toro G. (1974) Depression of plasma testosterone levels after chronic intensive marihuana use. N Engl J Med 290, 872–874.
32. Kumsar N, Kumsar S & Dilbaz N. (2016) Sexual dysfunction in men diagnosed as substance use disorder. Andrologia 48(10), 1229–1235.
33. Lacson J, Carroll J, Tuazon E, Castelao E, Bernstein L & Cortessis V. (2012) Population-based case-control study of recreational drug use and testis cancer risk confirms an association between marijuana use and nonseminoma risk. Cancer 118, 5374–5383.
34. Levine A, Clemenza K, Rynn M & Lieberman J. (2017) Evidence for the risks and consequences of adolescent cannabis exposure. J Am Acad Child Adolesc Psychiatry 56, 214–225.
35. Lewis S, Rapino C, Di Tommaso M, Pucci M, Battista N, Paro R, Simon L, Lutton D & Maccarrone M. (2012) Differences in the endocannabinoid system of sperm from fertile and infertile men. PLoS ONE 7, e47704.
36. Ligresti A, De Petrocellis L & Di Marzo V. (2016) From phytocannabinoids to cannabinoid receptors and endocannabinoids: Pleiotropic physiological and pathological roles through complex pharmacology. Physiol Rev 96, 1593–1659.
37. Maden C, Sherman K, Beckmann A, Hislop T, Teh C, Ashley R & Daling J. (1993) History of circumcision, medical conditions, and sexual activity and risk of penile cancer. J Natl Cancer Inst 85, 19–24.
38. McAllister S, Soroceanu L & Desprez P. (2015) The antitumor activity of plant-derived non-psychoactive cannabinoids. J Neuroimmune Pharmacol 10, 255–267.
39. McGlynn K & Cook M. (2009) Etiologic factors in testicular germ-cell tumors. Future Oncol 5, 1389–1402.
40. Mendelson J, Ellingboe J, Kuehnle J & Mello N. (1978) Effects of chronic marihuana use on integrated plasma testosterone and luteinizing hormone levels. J Pharmacol Exp Ther 207(2), 611–617.
41. Moller H, Prener A & Skakkebaek N. (1996) Testicular cancer, cryptorchidism, inguinal hernia, testicular atrophy, and genital malformations: Case-control studies in Denmark. Cancer Causes Control 7, 264–274.
42. Moller H, Cortes D, Engholm G & Thorup J. (1998) Risk of testicular cancer with cryptorchidism and with testicular biopsy: Cohort study. BMJ 317, 729.
43. Pacey A, Povey A, Clyma J, McNamee R, Moore H, Baillie H & Cherry N. (2014) Modifiable and non-modifiable risk factors for poor sperm morphology. Hum Reprod 29, 1629–1636.
44. Pertwee R & Fernando S. (1996) Evidence for the presence of cannabinoid CB1 receptors in mouse urinary bladder. Br J Pharmacol 118, 2053–2058.
45. Reece A & Hulse G. (2016) Chromothripsis and epigenomics complete causality criteria for cannabis- and addiction-connected carcinogenicity, congenital toxicity and heritable genotoxicity. Mutat Res 789, 15–25.
46. Reis L, Krapcho M, Mariotto A, Miller B, Feuer E, Clegg L, Horner M, Howlader N, Eisner M, Reichman M & Edwards B. SEER Cancer Statistucs Review, 1975-2004. National Cancer Institute 2007.
47. Rossato M, Pagano C & Vettor R. (2008) The cannabinoid system and male reproductive functions. J Neuroendocrinol 20(Suppl 1), 90–93.
48. Sharlip I, Jarow J, Belker A, Lipshultz L, Sigman M, Thomas A, Schlegel P, Howards S, Nehra A, Damewood M, Overstreet J & Sadovsky R. (2002) Best practice policies for male infertility. Fertil Steril 77, 873–882.
49. Sidney S, Quesenberry C, Friedman G & Tekawa I. (1997) Marijuana use and cancer incidence (California, United States). Cancer Causes Control 8(5), 722–728.
50. Smith A, Ferris J, Simpson J, Shelley J, Pitts M & Richters J. (2010) Cannabis use and sexual health. J Sex Med 7, 787–793.
51. Swerdlow A, Huttly S & Smith P. (1987) Testicular cancer and antecedent diseases. Br J Cancer 55, 97–103.
52. Swerdlow A, Higgins C & Pike M. (1997) Risk of testicular cancer in cohort of boys with cryptorchidism. BMJ 314, 1507–1511.
53. Tart C. (1970) Marijuana intoxication common experiences. Nature 226, 701–704.
54. Thomas A, Wallner L, Quinn V, Slezak J, Van Den Eeden S, Chien G & Jacobsen S. (2015) Association between cannabis use and the risk of bladder cancer: Results from the California Men's Health Study. Urology 85, 388–392.
55. Trabert B, Sigurdson A, Sweeney A, Strom S & McGlynn K. (2011) Marijuana use and testicular germ cell tumors. Cancer 117, 848–853.
56. United Nations Office on Drugs and Crime. (2017) World Drug Report 2017(ISBN: 978-92-1-148291-1, eISBN: 978-92-1-060623-3, United Nations publication, Sales No. E.17.XI.6).
57. Veening J, de Jong T, Waldinger M, Korte S & Olivier B. (2015) The role of oxytocin in male and female reproductive behavior. Eur J Pharmacol 753, 209–228.
58. Verhoeven R, Houterman S, Kiemeney B, Koldewijn E & Coebergh J. (2008) Testicular cancer: Marked birth cohort effects on incidence and a decline in mortality in southern Netherlands since 1970. Int J Cancer 122, 639–642.
59. Wade D, Robson P, House H, Makela P & Aram J. (2003) A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms. Clin Rehabil 17, 21–29.
60. Wall M, Brine DR & Perez-Reyes M. (1978) In: Technical Reports from Research Triangle Institute to National Institute on Drug Abuse. National Institute on Drug Abuse 1978, Rockville, Maryland.